Replies to post #8991 on Cytogenix (fka CYGX)

[lawrenceolivier]

Eightball:
You are correct:
There is a delivery problem. They still have not been able to delivery the actual medicine to the targeted cells. The stock was traded with a higher volume due to the time of the month. You noticed that the price did not go up much. Some investors were just getting some cash for their month end bills. The problem with some posters here is that they have such a big investment in CYGX thru the PPO's that they are praying for an uptick to make their first million. The problem is that will not happen until the delivery problem and a cure is found any disease. They have not solved this problem and this is the explanation for the continous delays and postponements in getting into true clinical. This board has no effect on the SP of CYGX. It is just a place to communicate ideas and opinions. There are many that have control issues and are afraid to hear anything against the management or lack of progress with this single strand DNA expression technology. Istill believe that the stock will be around 25 cents a share in thirty days. The longer the new financing is delayed the more likely that the stock will hit my prediction.